May 27, 2022

Volume XII, Number 147


May 27, 2022

Subscribe to Latest Legal News and Analysis

May 26, 2022

Subscribe to Latest Legal News and Analysis

May 25, 2022

Subscribe to Latest Legal News and Analysis

McDermottPlus Check-Up: June 4, 2021

This Week’s Dose

 Biden proposes a $6 trillion budget and a vaccination sprint. Proposed legislation looks to boost residency programs. 


Biden’s $6 Trillion Budget Outlines High Hopes for Healthcare

Building on the pared-down “skinny budget” released on April 9, the President released a full and more comprehensive budget plan on May 28.  The President’s full budget is an ambitious blueprint for White House policy priorities in a narrowly controlled Democratic Congress. For the U.S. Department of Health and Human Services (HHS), Biden’s proposal calls for $131.8 billion in discretionary budget authority and $1.5 trillion in mandatory funding—a 23% increase over 2021. This includes broad proposals to allow Medicare to negotiate prices for prescription drugs; expand Medicare benefits to include vision, dental and hearing coverage; lower the Medicare eligibility age to 60 years old and create a public option in the federal ACA exchange marketplace. It also calls for significant investments across HHS agencies to advance health equity.

White House Proposed ‘National Month of Action’ to Spur Vaccinations

The initiative seeks to have 70% of adults in the U.S. at least partially vaccinated by Independence Day. The Month of Action will engage celebrities, businesses and community organizations at national and local levels. From lotteries to sweepstakes to accommodations for travel and childcare, the Biden Administration hopes that these incentives will drive up lagging vaccination rates and raise the current nationwide percentage of around 50% to 70% in just four weeks. 


Doctors of Community (DOC) Act Would Enhance Graduate Medical Education

Senator Patty Murray (D-WA) and Representative Frank Pallone (D-NJ) are sponsoring a bill that would permanently authorize funding for the Teaching Health Center Graduate Medical Education (THCGME) program at $500 million annually from 2024-2033. By more than tripling the current level of funding, the DOC Act could help create 100 new THCGME programs targeted at high-need communities, as well as 1,600 new residency slots, largely concentrated at Federally Qualified Health Centers, Rural Health Clinics and tribal health centers. If passed, the DOC Act would be largest investment in THCGME programs in 20 years.

House Subcommittee Chair asks Government Accountability Office (GAO) to Investigate Private Equity Investment in Healthcare

In March, the House Ways and Means Oversight Subcommittee continued inquiries into the role and implications of private equity investment in healthcare interests, and specifically looked at the potential impact of private equity buyouts of healthcare providers with a specific focus on nursing homes. In that hearing, witnesses described a need for additional data and transparency to have a better understanding of how private equity ownership can impact quality of care. Now, the Oversight Subcommittee Chair, Bill Pascrell (D-NJ), has asked the GAO to look at trends in bankruptcies following private equity acquisition of healthcare providers; any geographic trends on buyouts followed by bankruptcies, including any disproportionate impact on underserved communities; and what is known about the impact of such bankruptcies on the healthcare workforce and patients. The panel’s request and the ensuing report are potentially setting the stage for future legislative action.

Quick Hits

  • Moderna has applied for full approval from the U.S. Food Drug Administration (FDA) for its COVID-19 vaccine. 

  • The U.S. Government Accountability office announced two new appointments and four reappointments to the Medicare Payment Advisory Commission (MedPAC).

  • The FDA released two final and two draft guidances to help stakeholders implement the next phases of the Drug Supply Chain Security Act. 

  • The White House released its initial strategy for global vaccine sharing and allocation. 

Next Week’s Diagnosis

The U.S. Supreme Court could hand down its decision on California v. Texas in a major ruling for the Affordable Care Act’s future. 

© 2022 McDermott Will & EmeryNational Law Review, Volume XI, Number 155

About this Author

Aaron Badida Healthcare Attorney McDermott

Aaron leverages a health-focused legal background with research and writing expertise to help clients analyze the impact of, and respond to, pending regulatory and legislative actions.

Aaron works with clients to provide data-driven insights to inform stakeholder comments on proposed regulations and tracks regulatory developments to ensure clients are engaged and informed on the policy matters that impact their businesses. He is also experienced in assessing Medicare payment regulations, as well as regulations from the Centers for Medicare & Medicaid Services, the Centers for...

1 202 756 8013
Mara McDermott, McDermott Law Firm, Washington DC, HealthCare Law Executive

Mara is an accomplished health care executive with a deep understanding of federal health care law and policy, including delivery system reform, physician payment and Medicare payment models.

Most recently Mara served as the senior vice president of federal affairs at America’s Physician Groups (formerly the California Association of Physician Groups, CAPG), a professional association representing medical groups and independent practice associations practicing in capitated, coordinated care models. As head of the Washington, DC, office, Mara...

Kristen O’Brien Healthcare Executive McDermott Consulting

Kristen O’Brien is an accomplished healthcare executive with a deep understanding of regulatory advocacy and healthcare policy efforts.

Kristen offers a strong background and a keen eye for solutions to barriers and challenges impacting healthcare clients. With more than 10 years of experience, her work focuses on implementing new laws through the rulemaking process, as well as working with relevant agency officials to develop and improve agency guidance.

Kristen recently served as Principal of the Health Industry Policy and Regulatory Practice Group at a law and lobbying...

Katie Waldo Healthcare Attorney

Katie is an experienced government relations strategist who helps clients navigate the complex issues surrounding Medicare, Medicaid and the healthcare marketplace.

Katie works with clients to represent their needs before the US Congress and the US Department of Health and Human Services (HHS) and its agencies by relying on extensive experience as a policy advisor on the Medicaid and Medicare programs, as well as the 340B program and other aspects of the Public Health Service Act. She anticipates the effects of state and federal policymaking on issues impacting their businesses and...

212 547 5433